These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19222695)

  • 1. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival.
    Petersson F; Diwan AH; Ivan D; Gershenwald JE; Johnson MM; Harrell R; Prieto VG
    J Cutan Pathol; 2009 Nov; 36(11):1157-63. PubMed ID: 19222695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion as a prognostic factor in melanoma.
    Egger ME; Gilbert JE; Burton AL; McMasters KM; Callender GG; Quillo AR; Brown RE; St Hill CR; Hagendoorn L; Martin RC; Stromberg AJ; Scoggins CR
    Am Surg; 2011 Aug; 77(8):992-7. PubMed ID: 21944512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.
    Weinlich G; Topar G; Eisendle K; Fritsch PO; Zelger B
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):669-77. PubMed ID: 17447982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with improved survival among young adult melanoma patients despite a greater incidence of sentinel lymph node metastasis.
    Chagpar RB; Ross MI; Reintgen DS; Edwards MJ; Scoggins CR; Martin RC; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; McMasters KM
    J Surg Res; 2007 Nov; 143(1):164-8. PubMed ID: 17950088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional recurrence after negative sentinel lymph node biopsy for melanoma.
    Carlson GW; Page AJ; Cohen C; Parker D; Yaar R; Li A; Hestley A; Delman KA; Murray DR
    Ann Surg; 2008 Sep; 248(3):378-86. PubMed ID: 18791358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of sentinel node status and other risk factors on the clinical outcome of head and neck melanoma patients.
    Leong SP; Accortt NA; Essner R; Ross M; Gershenwald JE; Pockaj B; Hoekstra HJ; Garberoglio C; White RL; Chu D; Biel M; Charney K; Wanebo H; Avisar E; Vetto J; Soong SJ;
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):370-3. PubMed ID: 16618904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging.
    Kimsey TF; Cohen T; Patel A; Busam KJ; Brady MS
    Ann Surg Oncol; 2009 May; 16(5):1176-83. PubMed ID: 19224283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
    Karakousis GC; Gimotty PA; Czerniecki BJ; Elder DE; Elenitsas R; Ming ME; Fraker DL; Guerry D; Spitz FR
    Ann Surg Oncol; 2007 May; 14(5):1596-603. PubMed ID: 17285396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple combinations of melanocytic and vascular endothelial markers enhance the detection rate of lymphovascular invasion in cutaneous melanoma.
    Bayram A; Ozturk Sari S; Ozluk Y; Tas F; Buyukbabani N
    J Cutan Pathol; 2021 Apr; 48(4):472-478. PubMed ID: 32935876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis.
    Doeden K; Ma Z; Narasimhan B; Swetter SM; Detmar M; Dadras SS
    J Cutan Pathol; 2009 Jul; 36(7):772-80. PubMed ID: 19032379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes.
    Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R
    Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study.
    Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F
    Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.